Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 2346Neoplasms 1710Prostatic Neoplasms 1192Lung Neoplasms 924Colorectal Neoplasms 877Carcinoma, Non-Small-Cell Lung 864Leukemia, Myeloid, Acute 592Pancreatic Neoplasms 578Multiple Myeloma 547Carcinoma, Hepatocellular 513Brain Neoplasms 511Neoplasm Metastasis 460Head and Neck Neoplasms 453Melanoma 415Ovarian Neoplasms 410Precursor Cell Lymphoblastic Leukemia-Lymphoma 400Glioblastoma 397Stomach Neoplasms 377Uterine Cervical Neoplasms 362Squamous Cell Carcinoma of Head and Neck 361Rectal Neoplasms 340Recurrence 334Sarcoma 324Hematologic Neoplasms 323Colonic Neoplasms 323Lymphoma 320Triple Negative Breast Neoplasms 292Carcinoma, Renal Cell 283Urinary Bladder Neoplasms 281Glioma 276

Interventions

bismuth tripotassium dicitrate 1S 1 (combination) 1Palliative Care 1Oxaliplatin 1Omeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Chemotherapy Effect × 1 year × Clear all
NCT06510010 2026-01-26

Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting
198 enrolled

Chemotherapy Effect

NCT05649852 2026-01-15

PASITHEA

GCS Ramsay Santé pour l'Enseignement et la Recherche

Phase NA Recruiting
192 enrolled

Chemotherapy Effect

Data powered by HemOnc (CC BY 4.0) Colophon âš¡